Featured Applications

Radiologist in the atrium of a modern-looking convention center
portable

Dedicated to your work. Not your workstation.

We realize you continue to be pushed to do even more in less time. You need new ways to reach quick, confident results. Xeleris V provides greater mobility, flexibility, and access by removing the limitations of a dedicated nuclear medicine workstation. Now you can go wherever your work takes you and still have powerful clinical insight close at hand.
Secure digital cloud with multiple nuclear medicine systems
virtual

It’s time to bring all of your data together

scalable

Easily scale from multi-user to multi-site

smart subscription

We’ve made it effortless to stay current

AI Video
ai

An AI for precision health

  • Segmentation

    It knows its way around anatomy. Automatically.
    Xeleris V AI-enabled clinical applications provide an accurate, efficient, and reproducible way to segment organs. With automatic deep learning-based applications, Xeleris V can automatically segment lung lobes for preoperative functional assessment of lung cancer cases. It can also automatically segment the lungs and trachea for evaluation of pulmonary embolism cases. This AI-enabled lung segmentation demonstrated an overall success rate of 89 percent1 and reduction in the number of clicks by an average of 57 percent2.

  • Quantitation

    A well-calculated plan
    AI-enabled clinical applications have the potential to greatly improve efficiency and precision in nuclear oncology. Xeleris V leverages AI to accurately segment organs for quantitation and dosimetry calculations. Q.Thera AI demonstrated an average reduction of 58% in the time required for the user to process and calculate dose3.

Clinical Applications
clinical applications

Everything you need to do great work

Xeleris V Base Package Applications

Advanced Reconstruction Package Applications

Quantitation Package Applications

  • Q.Volumetrix AI

    Q. Volumetrix AI software enables advanced segmentation and quantitation capabilities for SPECT/CT and PET/CT data without impeding workflow for both baseline and longitudinal studies.

  • Q.Lung AI

    Q.Lung AI offers a deep learning-based SPECT/CT lung lobe segmentation application, fast and reproducible lung lobe segment analysis, and a guided auto analysis of quantitative lobal and lung function. It also offers trachea segment masking for pulmonary embolism evaluation.

Cardiology Reconstruction Package Applications

Neurology Package Applications

Dosimetry Package Applications

  • Q.Thera AI

    Q.Thera AI segments lesion volumes and can automatically segment organs, as well as quantify and calculate the percent of injected and absorbed dose per organ and lesion. This simplified process saves you time while providing clear and confident results.

  • Q.Liver

    The Q.Liver application offers an enhanced workflow for assessing liver anatomy, an automatic method for liver segmentation, and a single platform to facilitate dose calculation. It’s a one-stop-shop for processing, quantifying, and reviewing liver SPECT/CT as well as tools provided to the user to calculate the therapeutic SIRT treatment doses using a user defined formula.
Third party Applications
Smart Subscription
smart subscription

MI systems that keep getting better

Summary

Let’s put Xeleris V to work for your enterprise

Images are for illustration purposes only. See Xeleris V minimum requirements for supported client devices.

Quantitative Perfusion SPECT, Quantitative Gated SPECT, Quantitative Blood Pool GSPECT and Automatic Report Generator are trademarks of Cedars Sinai.

Emory Toolbox, Emory SyncTools, Emory SmartReport and Emory PETtools are trademarks of Syntermed Medical Imaging.

ASNC ImageGuide is a trademark of the American Society of Nuclear Cardiology.

Xeleris, Edison and Discovery are trademarks of GE.

1As demonstrated in an evaluation consisting of 99 SPECT/CT cases and three physicians, where each case was segmented manually and using the AI-based algorithm and evaluated by one of the physicians. In 89 of the cases, the AI-based segmentation met the success criteria of (a) less than three manual edits, and (b) lobe volume and activity within a predefined threshold compared to manual segmentation.

2Compared to Q.Lung on Xeleris 4 DR. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow for pulmonary embolism diagnosis and lung function assessment. Results may vary.

3Compared to using Xeleris 4 DR Dosimetry Toolkit with dose calculations done manually or with external software. As demonstrated in an evaluation at two sites consisting of 14 SPECT/CT cases by four physicists, where each case was processed by one of the four physicists. Results may vary.

4Applicable for SPECT from Discovery NM/CT 670 CZT and NM/CT 870 CZT.

5Applicable for Discovery NM/CT 530c and Discovery NM/CT 570c.

6Compared to using Xeleris 4 DR Q.Volumetrix MI. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.

7Compared to using Xeleris 4 DR Q.Volumetrix MI with manual or external software dose calculation. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.

8Compared to using Xeleris 4 DR Q.Volumetrix with manual or external software dose calculation. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow from data loading to dose calculation using user pre-defined formulas. Results may vary.

JB00550CA